๐ก Atrial Natriuretic Peptide (ANP): A peptide hormone that acts as a vasodilator ๐ซ, diuretic ๐ง, and natriuretic (Naโบ-excreting) agent.
It suppresses sympathetic tone and the RAAS, playing a key role in blood pressure and fluid balance regulation.
๐ About
- Source: Secreted mainly by atrial myocytes (RA > LA) in response to stretch/โ blood volume. Ventricles contribute in severe overload (HF).
- Structure: 28-amino acid peptide, acts via โ intracellular cGMP.
- Degradation: Broken down by neutral endopeptidases.
โ๏ธ Effects
- Renal:
- โ GFR by dilating afferent & constricting efferent arterioles.
- โ Naโบ reabsorption (via ENaC inhibition in distal nephron).
- โ Diuresis + natriuresis โ โ circulating volume.
- Vascular: Potent vasodilation โ โ systemic vascular resistance & BP.
- Systemic: Suppresses sympathetic activity + RAAS. Regulates Naโบ, Kโบ, fluid & adipose metabolism.
๐งฌ Mechanism of Action
- ANP binds to natriuretic peptide receptor-A (NPR-A).
- Activates guanylyl cyclase โ โ cGMP โ
- Relaxed vascular smooth muscle.
- Inhibition of Naโบ reabsorption in renal tubules.
- โ Aldosterone secretion (adrenal cortex).
๐ฉบ Clinical Relevance
- Elevated ANP: Seen in hypervolemia โ Heart Failure โค๏ธ, CKD, Liver Cirrhosis (ascites).
- Marker: ANP & BNP are used as biomarkers of HF severity & fluid overload.
- Exam Pearl: BNP is more commonly measured, but both rise in HF โ helpful in dyspnoea differentials.
๐ Uses
- ANP analogues/related drugs under study for:
- Acute decompensated heart failure.
- Refractory hypertension.
- Renal disorders with volume overload.
๐ References